Organogenesis Holding (NASDAQ: ORGO) reported Q1 EPS of ($0.17), $0.13 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $86.69 million versus the consensus estimate of $90.77 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.